Connection

Klaus Überla to Seroconversion

Back to Details
This is a "connection" page, showing publications Klaus Überla has written about Seroconversion.
Klaus Überla
Connection Strength
0.102
Seroconversion
  1. Patients with immune-mediated inflammatory diseases receiving cytokine inhibitors have low prevalence of SARS-CoV-2 seroconversion. Nat Commun. 2020 07 24; 11(1):3774.
    View in: PubMed
    Score: 0.102
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.